AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | +33.8% | 20,047 | +19.6% | 0.02% | +25.0% |
| Q1 2023 | $154 | +40.0% | 16,759 | +9.5% | 0.02% | +6.7% |
| Q4 2022 | $110 | -99.8% | 15,310 | +45.2% | 0.02% | +200.0% |
| Q3 2022 | $53,000 | -74.1% | 10,541 | -58.5% | 0.01% | -76.2% |
| Q4 2021 | $205,000 | +111.3% | 25,427 | +75.8% | 0.02% | +110.0% |
| Q4 2020 | $97,000 | -63.7% | 14,461 | -56.2% | 0.01% | -67.7% |
| Q2 2020 | $267,000 | +151.9% | 33,048 | +155.0% | 0.03% | +416.7% |
| Q4 2017 | $106,000 | -23.7% | 12,959 | -1.9% | 0.01% | -14.3% |
| Q3 2017 | $139,000 | – | 13,208 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |